Video

Experts Highlight Ongoing Research Efforts Across Tumor Types

Author(s):

OncLive Staff

OncLive interviewed experts at the State of the Science Summits in June 2019 on research being conducted at their respective institutions.

OncLive interviewed experts at the State of the Science Summits in June 2019 on research being conducted at their respective institutions.

Related Videos
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD
Jonathan Wesley Riess, MD, MS, an associate professor at the University of California (UC) Davis
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Laura A. Huppert, MD
Polly Niravath, MD
Arvind N. Dasari, MD, MS
Charles E. Geyer, Jr., MD
Sattva S. Neelapu, MD
Related Content
stock.adobe.com
December 30th 2024

Transparency and Consolidation Issues Hamper 340B Program in Cancer Care

Sorting Through Sexism, Guilt, and Motherhood in Medicine
January 27th 2022

Sorting Through Sexism, Guilt, and Motherhood in Medicine

Jairam Krishnamurthy, MD, FACP
November 22nd 2024

Category 1 Recommendation of Ribociclib Plus an AI Represents Huge Advancement in Breast Cancer

Gilbert on Gaining New Ground at Vanderbilt
January 3rd 2022

Gilbert on Gaining New Ground at Vanderbilt

Jeff Patton, MD
September 24th 2024

Medicare Drug Price Negotiations Will Have Domino Effect for Community Oncology Practices

Kimberly Futch, MBA
September 23rd 2024

AI Is Poised to Influence Several Areas of Cancer Care With Some Fine-Tuning